3/27
07:05 am
syrs
Form S-8 Syros Pharmaceuticals,
Medium
Report
Form S-8 Syros Pharmaceuticals,
3/27
06:50 am
syrs
Form 10-K Syros Pharmaceuticals, For: Dec 31
Medium
Report
Form 10-K Syros Pharmaceuticals, For: Dec 31
2/14
08:56 pm
syrs
Form SC 13G Syros Pharmaceuticals, Filed by: Blue Owl Capital Holdings LP
Low
Report
Form SC 13G Syros Pharmaceuticals, Filed by: Blue Owl Capital Holdings LP
2/13
08:23 pm
syrs
Form SC 13G/A Syros Pharmaceuticals, Filed by: Avidity Partners Management LP
Low
Report
Form SC 13G/A Syros Pharmaceuticals, Filed by: Avidity Partners Management LP
2/13
07:02 pm
syrs
Form SC 13G/A Syros Pharmaceuticals, Filed by: Ally Bridge MedAlpha Master Fund L.P.
Low
Report
Form SC 13G/A Syros Pharmaceuticals, Filed by: Ally Bridge MedAlpha Master Fund L.P.
2/13
06:59 pm
syrs
Form SC 13G/A Syros Pharmaceuticals, Filed by: Bain Capital Life Sciences Fund II, L.P.
Low
Report
Form SC 13G/A Syros Pharmaceuticals, Filed by: Bain Capital Life Sciences Fund II, L.P.
2/9
05:09 pm
syrs
Form SC 13G/A Syros Pharmaceuticals, Filed by: Artal International S.C.A.
Low
Report
Form SC 13G/A Syros Pharmaceuticals, Filed by: Artal International S.C.A.
2/7
07:09 am
syrs
Form SC 13G/A Syros Pharmaceuticals, Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
Low
Report
Form SC 13G/A Syros Pharmaceuticals, Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
1/8
07:07 am
syrs
Form 8-K Syros Pharmaceuticals, For: Jan 08
Medium
Report
Form 8-K Syros Pharmaceuticals, For: Jan 08
1/2
04:16 pm
syrs
Form SC 13G Syros Pharmaceuticals, Filed by: Point72 Asset Management, L.P.
Medium
Report
Form SC 13G Syros Pharmaceuticals, Filed by: Point72 Asset Management, L.P.